Glenview Capital Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Glenview Capital Management, LLC
- $5.08 Billion
- Q2 2024
A detailed history of Glenview Capital Management, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Glenview Capital Management, LLC holds 26,500,000 shares of DNA stock, worth $205 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
26,500,000
Previous 24,000,000
10.42%
Holding current value
$205 Million
Previous $27.8 Million
68.59%
% of portfolio
0.17%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding DNA
# of Institutions
248Shares Held
887MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.08 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.04 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$541 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$326 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.98B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...